These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22848498)

  • 1. Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.
    Gong B; Kielar C; Morton AJ
    PLoS One; 2012; 7(7):e41450. PubMed ID: 22848498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
    Wang J; Wang CE; Orr A; Tydlacka S; Li SH; Li XJ
    J Cell Biol; 2008 Mar; 180(6):1177-89. PubMed ID: 18362179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
    Mitra S; Tsvetkov AS; Finkbeiner S
    J Biol Chem; 2009 Feb; 284(7):4398-403. PubMed ID: 19074152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation.
    Zucchelli S; Marcuzzi F; Codrich M; Agostoni E; Vilotti S; Biagioli M; Pinto M; Carnemolla A; Santoro C; Gustincich S; Persichetti F
    J Biol Chem; 2011 Jul; 286(28):25108-17. PubMed ID: 21454471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
    Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
    FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
    Tydlacka S; Wang CE; Wang X; Li S; Li XJ
    J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
    Wanderer J; Morton AJ
    Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients.
    Seo H; Kim W; Isacson O
    Hum Mol Genet; 2008 Oct; 17(20):3144-53. PubMed ID: 18640989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease.
    Hipp MS; Patel CN; Bersuker K; Riley BE; Kaiser SE; Shaler TA; Brandeis M; Kopito RR
    J Cell Biol; 2012 Mar; 196(5):573-87. PubMed ID: 22371559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.
    Jia H; Kast RJ; Steffan JS; Thomas EA
    Hum Mol Genet; 2012 Dec; 21(24):5280-93. PubMed ID: 22965876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
    Martín-Aparicio E; Yamamoto A; Hernández F; Hen R; Avila J; Lucas JJ
    J Neurosci; 2001 Nov; 21(22):8772-81. PubMed ID: 11698589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Proteome and Ubiquitinome Changes in the Soluble and Insoluble Fractions of Q175 Huntington Mice Brains.
    Sap KA; Guler AT; Bezstarosti K; Bury AE; Juenemann K; Demmers JA; Reits EA
    Mol Cell Proteomics; 2019 Sep; 18(9):1705-1720. PubMed ID: 31138642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Differential Profiling of Ubiquitin-Proteasome and Autophagy Systems in Different Tissues before the Onset of Huntington's Disease Models.
    Her LS; Lin JY; Fu MH; Chang YF; Li CL; Tang TY; Jhang YL; Chang CY; Shih MC; Cheng PH; Yang SH
    Brain Pathol; 2015 Jul; 25(4):481-90. PubMed ID: 25178567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.
    Hunter JM; Lesort M; Johnson GV
    J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.
    Hakim-Eshed V; Boulos A; Cohen-Rosenzweig C; Yu-Taeger L; Ziv T; Kwon YT; Riess O; Phuc Nguyen HH; Ziv NE; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18661-18669. PubMed ID: 32675242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome activator enhances survival of Huntington's disease neuronal model cells.
    Seo H; Sonntag KC; Kim W; Cattaneo E; Isacson O
    PLoS One; 2007 Feb; 2(2):e238. PubMed ID: 17327906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.